Atlas Trials

Sublingual Apomorphine in Refractory Restless Legs Syndrome

Clinical trial NCT05529095 · UNKNOWN

Trial details

NCT number
NCT05529095
Sponsor
William Ondo, MD
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Restless Legs Syndrome
Start date
2022-09-01
Primary completion
2023-03-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.